Discover 1,416 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,416
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
for
Acute Stroke, Ischemic Stroke, Stroke
Location: Sarasota FL, Tampa FL, Atlantis FL, Boca Raton FL,
Sponsor: DiaMedica Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT05065216
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Sarasota FL, West Palm Beach FL, Miami Beach FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Sarasota FL, Mobile AL, Atlanta GA, Birmingham AL,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
for
Recurrent Melanoma (Skin), Metastatic Melanoma,
Location: Sarasota FL, Miami FL, Jacksonville FL, Chapel Hill NC,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05655312
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy